Nicolas Penel

25PUBLICATIONS
184CO-AUTHORS
Disease surveillanceCheminformatics and quantitative structure-activity relationshipsPharmacogenomicsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 02, 2024
Active Surveillance in Patients with Extra-abdominal Desmoid-Type Fibromatosis: A Pooled Analysis of Three Prospective Observational Studies.

Chiara Colombo, Stefanie Hakkesteegt, Axel Le Cesne

|Sep 16, 2024
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.

Brian Belmontes, Katherine K Slemmons, Chun Su

|Mar 25, 2024
Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study.

Côme De Metz, Benjamin Hennart, Estelle Aymes

|Jan 22, 2024
Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF).

Noémie Huchet, Nicolas Penel, Sylvie Bonvalot

|Nov 02, 2023
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.

Florence Duffaud, Jean-Yves Blay, Axel Le Cesne

|Sep 11, 2023
Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer.

Pauline Parent, Gautier Marcq, Sola Adeleke

Pageof 5

Frequent Collaborators

8 joint publications

Jean-Yves Blay

4 joint publications

Sylvie Bonvalot

2 joint publications

Emmanuelle Bompas

2 joint publications

Maud Toulmonde